8.2% overall MARD5
The lower the MARD, the more accurate the results
The easy choice for your patients
Easy and convenient
The ease of the FreeStyle Libre 2 system,2 now with 15-day sensor wear
Real-time
Glucose readings every minute, sent right to your patients’ smartphones◊,¤
Outstanding accuracy
including strong low-end performance5
Now indicated for ages 2+
The Libre 2 Plus sensor is indicated for patients 2 years and older whereas the Libre 2 is indicated for patients 4 years and older.^

Proven 15-day accuracy5
99.9% of readings in Zones A and B of the Consensus Error Grid5,6 without the need for finger prick calibration
Outstanding accuracy in the low glucose range (<3.9 mmol/L)—98.9% within ±1.1 mmol/L5
Unsurpassed 15-day accuracy, including dependable clinical performance5
Both sensors in the FreeStyle Libre 2 system have a high degree of clinical accuracy, with 99.9% of readings in Zones A and B of the Consensus Error Grid without the need for finger prick calibration.5,6
Consensus Error Grid
for Libre 2 Plus sensor
- 8.2% MARD5
- Outstanding accuracy in the low glucose range (<3.9 mmol/L): 98.9% within ±1.1 mmol/L5
Consensus Error Grid
for Libre 2 sensor
for Libre 2 sensor
- 9.2% MARD6
- Outstanding accuracy in the low glucose range (<3.9 mmol/L): 98.4% within ±1.1 mmol/L6
Libre 2 Plus Sensor Works With

LibreLink App
Real-time glucose readings from the Libre 2 Plus sensor are automatically updated every minute and sent directly to the LibreLink app on your patients' smartphones.¤,◊
LibreView
Using LibreView,₼ our secure7 cloud-based system, patients can upload their data to share with their doctor and care team. You will be able to access more in-depth reports to support you in making informed treatment decisions for your patients.
LibreLinkUp
With the free LibreLinkUp§ app, your patients’ family members get real-time accessǁ to their glucose information and customisable alarms.
References & Disclaimers
Images are for illustrative purposes only. Not real patient or data.
1. Data on file, Abbott Diabetes Care, Inc. Among leading brands based on market share.
2. Haak, T. Diabetes Therapy (2017): https://doi.org/10.1007/s13300-016-0223-6.
3. Based on FDA iCGM special controls. Accessed August 2023 from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=862.1355.
4. Adult cohort, N=149. Lower one-sided 95% confidence bound of the percentage of measurements within ±20% exceeds iCGM benchmark of 87%.
5. Data on file, Abbott Diabetes Care, Inc.
6. Alva, S. J Diabetes Sci Technol (2020): https://doi.org/10.1177/1932296820958754.
7. LibreView is ISO27001/27018/27701 certified and HITRUST CSF Certified.
¤ Glucose readings are automatically displayed in the FreeStyle LibreLink app only when the smartphone and sensor are connected and in range.
◊ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Sharing of glucose data require registration with LibreView.
^ For children aged 2-12 using FreeStyle Libre 2 Plus sensor, a caregiver at least 18 years old is responsible for supervising, managing, and assisting them in using the FreeStyle Libre 2 system and interpreting its readings. For children aged 4-12, using FreeStyle Libre 2 sensor a caregiver at least 18 years old is responsible for supervising, managing, and assisting them in using the FreeStyle Libre 2 system and interpreting its readings.
₼ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
§ The FreeStyle LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
ǁ The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
ADC-119414 v1.0
Stay connected